IXHL
Incannex Healthcare Inc.
Key Financials
Operating Income
$-23789000
↑ 20.8%
Revenue
$12000
N/A
Net Income
$-46885000
↓ 154.0%
EPS (Diluted)
$-1.35
↓ 17.4%
Total Liabilities
$7.1M
↑ 21.1%
Total Assets
$20.4M
↑ 19.9%
Cash & Equivalents
$15.0M
↑ 156.7%
Shareholders' Equity
$13.4M
↑ 19.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 6/25/2026 | View on SEC |
| 8-K | 6/10/2026 | View on SEC |
| 8-K | 6/9/2026 | View on SEC |
| 10-Q | 5/15/2026 | View on SEC |
| 8-K | 5/14/2026 | View on SEC |
| 8-K | 5/12/2026 | View on SEC |
| 8-K | 4/22/2026 | View on SEC |
| 8-K | 3/27/2026 | View on SEC |
| 8-K | 3/25/2026 | View on SEC |
| 8-K | 3/18/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IXHL |
| Company Name | Incannex Healthcare Inc. |
| CIK | 1873875 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | DE |
| Phone | 61 409 840 786 |